FDA Expecting 250,000 Cans of Nestle Baby Formula in June, July
02 Junho 2022 - 12:43PM
Dow Jones News
By Chris Wack
The U.S. Food and Drug Administration on Thursday said it is
expecting 249,500 cans of Nestle SA's NAN Supreme Pro 1 and NAN
Supreme Pro 2 baby formula to be available in June and July.
The FDA said the U.S. Department of Health and Human Services is
evaluating options for getting Nestle's products to the U.S. as
quickly as possible.
The Nestle cans hold about 440,000 pounds of formula, or nearly
6.5 million full-size, 8-ounce bottles, the agency said.
The FDA said it is exercising enforcement discretion to import
the infant formula products, following the review of nutritional
adequacy and safety, as well as facility production and inspection.
The FDA has encouraged overseas manufacturers to apply to ship
their formula to the U.S., easing rules that had effectively
prevented shipments from many such companies.
The agency said it remains in further discussions with
manufacturers and suppliers regarding additional supply.
Baby formula has been in short supply for months partly because
of supply-chain issues caused by the Covid-19 pandemic. Product
recalls and a production halt by Abbott have exacerbated the
shortages.
The FDA said it expects the potential for Abbott Laboratories'
Sturgis, Mich., facility to safely resume production in the
near-term to lead to additional supply. Abbott closed its Sturgis
plant, which makes Similac and other brands, in February after the
FDA said it found the presence of a germ called cronobacter
sakazakii, which can be deadly in infants, in the factory.
The FDA said it continues to advise the public against making
infant formulas at home or diluting formula.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
June 02, 2022 11:28 ET (15:28 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024